2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Changes in Serum Lipids During Treatment with Norgestrel, Oestradiol-Valerate and Cycloprogynon®

, , , &
Pages 367-370 | Published online: 09 Jul 2009

References

  • Beck P. Alterations of lipid metabolism by contraceptive steroids. J Steroid Biochem 1975; 6: 957
  • Borglin N. E., Staland B. Oral treatment of menopausal symptoms with natural oestrogens. Acta Obstet Gynecol Scand 1975; 1, Suppl. 43
  • Borenstein R., Stahl N. L., Greenblatt R. B. Effects of sex steroids on lipid levels. J Am Geriat Soc 1972; 20: 369
  • Briggs M. Minimizing the metabolic effects of oral contraceptives. Bull Post-Grad Comm Med, Sydney 1975; 31: 175
  • Christensen N. C., Davidsen P. C., Secher N. J., Pedersen Thomsen G. Serum lipids during oestradiol valerate/norgestrel treatment of menopausal women. Acta Obstet Gynecol Scand 1975; 54: 213
  • Donde U. M., Virkar K. Effect of contraceptive steroids on serum lipids. Am J Obstet Gynecol 1975; 123: 136
  • Eckstein P., Whitby M., Fotherby K., Butler C., Mukherjee T. K., Burnett J. C., Richards D. J., Whitehead T. P. Clinical and laboratory findings in a trial of norgestrel, a low-dose progestogen—only contraceptive. Br Med J 1972; 3: 195
  • Eggstein M., Kreutz F. H. Eine neue Bestimmung der Neutralfette im Serum und Gewebe. Klin Wschr 1966; 44: 262
  • Huang T. C., Chen C. P., Wefler V., Raftery A. A. A stable reagent for the Liebermann-Burchard reaction. Anal Chem 1961; 33: 1405
  • Kuku S. B., Akinyanju P. A. Fasting serum lipids and serum lipoprotein distribution during oral contraceptive therapy in Nigerians. J Obstet Gynaecol Br Comm 1973; 80: 750
  • Lauritzen C. The female climacteric syndrome: Significance, problems, treatment. Acta Obstet Gynecol Scand 1975; 49, Suppl 51
  • Lebech P. E., Borggaard B. Klimakteriet. Danmarks Apotekerforening, København symposium 1973; 80
  • Lebech P. E., Borggaard B. Serum lipid and antithrombin-III changes effected by synthetic and natural estrogen therapy. The Menopausal Syndrome, Greenblatt B. Robert, Mahesh M. Virendra, McDonough G. Paul. Medcom Press. 1973; 68
  • Nielsen F. H. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraceptive. Acta Obstet Gynecol Scand 1974; 53: 13
  • Pyörälä T. The effect of synthetic and natural estrogens on glucose tolerance, plasma insulin and lipid metabolism in post-menopausal women. In The Management of the Menopause & Post-Menopausal Years, Stuart, Campbell. MTP Press Ltd., LancasterEngland 1976; 195, Proc. International Symposium, London, 2 4–26 November 1975
  • Schneider W. H. F., Matt K., Irsigler K., Lageder H., Schubert H. Gynäkologische, hämatologische und Stoffwechseluntersuchungen unter der Therapie mit einem Östrogen-Gestagen-Kombinationspräparat. Artzneim Forsch 1975; 25: 959
  • Spellacy W. N., Buhi W. C., Birk S. A. Norgestrel and carbohydrate-lipid metabolism: glucose, insulin and triglyceride changes during six months time of use. Contraception 1974; 9: 615
  • Utian W. H. Clinical and metabolic effects of the menopause and the role of replacement oestrogen therapy. Thesis, University of Cape Town 1970; 65
  • Wynn V., Adams P., Oakley N., Seed M. Metabolic investigations in women taking 30 μg ethinyloestradiol plus 150 μg d. norgestrel. Proceedings of the Second International Norgestrel Symposium 1974; 47, Exc Med Amsterdam

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.